Luteolin induces growth arrest in colon cancer cells through involvement of Wnt/β-catenin/gsk-3β signaling

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 32, Issue 2, 2013, Pages 131-139

  Pandurangan, Ashok Kumar ^a   Dharmalingam, Prakash ^a   Sadagopan, Suresh Kumar Ananda ^a   Ramar, Manikandan ^a   Munusamy, Arumugam ^a   Ganapasam, Sudhandiran ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

catenin; Apoptosis; Colon cancer; HCT 15; Luteolin

Indexed keywords

BETA CATENIN; CASPASE 3; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; LUTEOLIN; PROTEIN BAX; PROTEIN BCL 2; TRYPAN BLUE; WNT PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL ASSAY; CELL PROLIFERATION; CELL VIABILITY; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BETA CATENIN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; G2 PHASE CELL CYCLE CHECKPOINTS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LUTEOLIN; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

EID: 84884137005     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.2013007522     Document Type: Article

References (52)

1. Horn-Ross PL, Barnes S, Lee M, Coward L, Mandel JE, Koo J, John EM, Smith M. Assessing phytoes-trogen exposure in epidemiologic studies: development of a database (United States). Cancer Causes Control. 2000;11:289-298.
2. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast cancer risk in Singapore. Lancet. 1991:337:1197-1200.
3. Reddy BS, Cohen LA, eds. Diet and colon cancer. In: Evidence from human and animal model studies. Boca Raton, FL: CRC Press; 1986. pp. 47-65.
4. Slattery ML, Benson J, Curtin K, Ma KN, Scaeffer D, Potter JD. Carotenoids and colon cancer. Am J Clin Nutr. 2000;71:575-582.
5. Giovannucci E, Stampfer MJ, Colditz G, Rimm EB, Willett WC. Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst. 1992;84:91-98.
6. Perez-Garcia F, Adzet T, Canigueral S. Activity of artichoke leaf extract on reactive oxygen species in human leukocytes. Free Radic Res. 2000;33:661-665.
7. Kim, HK, Cheon BS, Kim SY, Kim HP. Effects of naturally occurring favonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure and activity relationships. Biochem Pharmacol. 1999;58:759-765.
8. Ashokkumar P, Sudhandiran G. Protective role of luteolin on the status of lipid peroxidation and an-tioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomed Phar-macother. 2008;62:590-597.
9. Pandurangan AK, Dharmalingam P, Anandasadago-pan SK, Ganapasam S. Effect of luteolin on the levels of glycoproteins during azoxymethane-induced colon carcinogenesis in mice. Asian Pac J Cancer Prev. 2012:13:1569-1573.
10. Veda H, Yamazaki C, Yamazaki M. Luteolin as an anti-infammatory and anti-allergic constituent of Perilla frutescens. Biol Pharm Bull. 2002;25:1197-1202.
11. Ashokkumar, P, Sudhandiran G. Luteolin inhibits cell proliferation during azoxymethane-induced experimental colon carcinogenesis via wnt/β-catenin pathway. Invest New Drugs. 2011;29:273-284.
12. Wong NA, Pignatelli M. Beta-catenin-a linchpin in colorectal carcinogenesis? Am J Pathol. 2002;160:389-401.
13. Herbst A, Kolligs FT. Wnt signaling as a therapeutic target for cancer. Methods Mol Biol. 2007;361:63-91.
14. Luo J, Chen J, Deng ZL, Luo X, Song WX, Sharff KA, Tang N, Haydon RC, Luu HH, He TC. Wnt signaling and human diseases: what are the therapeutic implications? Lab Invest. 2007;87:97-103.
15. Rasola A, Geuna M. A flow cytometry assay simultaneously detects independent apoptotic parameters. Cytometry. 2001;45:151-157.
16. Sriram N, Kalayarasan S, Ashokkumar P, Suresh-kumar A, Sudhandiran G. Diallyl sulfde induces apoptosis in Colo 320 DM human colon cancer cells: involvement of caspase-3, NF-κB, and ERK-2. Mol Cell Biochem. 2008;311:157-165.
17. Jaszewski R, Millar B, Hatfeld JS, Nogothu K, Finkenauer R, Rishi AK, Naumoff JA, Kucuk O, Axelrod BN, Majumdar AP. Folic acid reduces nuclear translocation of β-catenin in rectal mucosal crypts of patients with colorectal adenomas. Cancer Lett. 2004;206:27-33.
18. Du Q, Park KS, Guo Z, He P, Nagashima M, Shao L, Sahai R, Geller DA, Hussain SP. Regulation of human nitric oxide synthase 2 expression by Wnt/β-Catenin signaling. Cancer Res. 2006;66:7024-7031.
19. Tsuchiya K, Nakamura Y, Okamoto R, Kanai T, Watanabe M. Reciprocal targeting of Hath1 and beta-Catenin by Wnt glycogen synthase kinase 3 beta in human colon cancer. Gastroenterology. 2007;132:208-220.
20. Herman-Antosiewicz A, Singh S V. Signal transduc-tion pathways leading to cell cycle arrest and apop-tosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. Mutat Res. 2004;555:121-131.
21. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
22. Salvesen GS, Dixit VM. Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A. 1999;96:10964-10967.
23. Cowin P. Unraveling the cytoplasmic interactions of the cadherin superfamily. Proc Natl Acad Sci U S A. 1994;91:10759-10761.
24. Huber AH, Weis WI. The structure of the β-catenin/ E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin. Cell. 2001;105:391-402.
25. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 2003;1653:1-24.
26. Nelsson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science. 2004;303;1483-1487.
27. Lustig B, Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol. 2003;129:199-221.
28. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, llyas M, Bodmer WF, Moyer MP, Riecken EO, Buhr HJ, Hanski C. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A. 1999;96:1603-1608.
29. Raju J, Bird RP. Diosgenin, a naturally occurring furostanol saponin suppresses 3-hydroxy-3-meth-ylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells. Cancer Lett. 2007;255:194-204.
30. Kumar A, Pandurangan AK, Lu F, Fyrst H, Zhang M, Byun HS, Bittman R, Saba JD. Chemopreventive sphigadienes downregulate Wnt signaling via a PP2A/Akt/GSK3β pathway in colon cancer. Car-cinogenesis. 2012;33:1726-1735.
31. Xiang D, Wang D, He Y, Xie J, Zhong Z, Li Z, Xie J. Caffeic acid phenyl ester induces growth arrest and apoptosis of colon cancer cells via the β-catenin/T-cell factor signaling. Anticancer Drugs 2006;17:753-762.
32. Park CH, Chang JY, Hahm ER, Park S, Kim HK, Yang CH. Quercetin, potent inhibitor against the β-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun. 2005;328:227-234.
33. Jaiswal AS, Marlow BP, Gupta N, Narayan S. β-Catenin mediated transactivation and cell-cell adhesion pathways are important in cur-cumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cell. Oncogene. 2002;21:8418-8427.
34. Pandurangan AK. Potential targets for the prevention of colorectal cancer: a focus on PI3K/Akt/ mTOR and Wnt pathways. Asian Pac J Cancer Prev. 2013;14:2201-2205.
35. Patel R, Ingle A, Maru GB. Polymeric black tea polyphenols inhibit 1,2-dimethylhydrazine induced carcinogenesis by inhibiting cell proliferation via Wnt/β-catenin pathway. Toxicol Appl Pharmacol. 2008;227:136-146.
36. Bartkova J, Lukas J, Muller H, Strauss M, Guster-son B, Bartek J. Abnormal patterns of D-type cy-clin expression and G1 regulation in human head and neck cancer. Cancer Res. 2003;55:949-956.
37. Masciullo V, Scambia G, Marone M, Giannitelli C, Ferrandina G, Bellacosa A, Benedetti Panici P, Mancuso S. Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas. Int J Cancer. 1997;74:390-395.
38. Arber N, Doki Y, Han, EKH, Sgambato A, Zhou P, Kim NH, Delohery T, Klein MG, Holt PR, Wein-stein IB. Antisense to cyclin Dl inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 1997;57:1569-1574.
39. Zhang T, Nanney LB, Luongo C, Lamps L, Hep-pner KJ, DuBois RN, Beauchamp RD. Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenoma polyposis patients. Cancer Res. 1997;57:169-175.
40. Mueller A, Odze R, Jenkins TD, Shahsesfaei A, Nakagawa H, Inomoto T, Rustgi AK. A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities. Cancer Res. 1997;57:5542-5549.
41. Kirkin V, Joos S, Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta. 2004;1644:229-249.
42. Lucken-Ardjomande S, Martinou JC. Regulation of Bcl-2 proteins and of the permeability of the outer mitochondrial membrane. C R Biol. 2005;328:616-631.
43. Nicholson DW, Ali A, Thornberry NA, Vallan-cout JP, Ding Ck, Gallant M, Gareau Y, Griffn PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK. Identification and inhibition of the ICE/CED3 protease necessary for mammalian apoptosis. Nature. 1995;376:37-43.
44. Talanian RV, Quinlan C, Jtrautz S, Hackett MC, Mankovich, JA, Banach D, Ghayur T, Brady KD, Wong WW. Substrate specifcities of caspase family proteases. J Biol Chem. 1997;272:9677-9682.
45. Sharma K, Wang RX, Zhang LY, Yin DL, Luo Xy, Solomon JC, Jiang RF, Markos K, Davidson W, Scott DW, Shi YF. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther. 2000;88:333-347.
46. Gross A, McDonnell JM, Korsmeyer SJ. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13:1899-1911.
47. Kluck RM, Bossy-wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apopto-sis. Science. 1997;275:1132-1136.
48. Cohen GM. Caspases: the executioners of apopto-sis. Biochem J. 1997;326:1-16.
49. Lee LT, Huang YT, Hwang JJ, Lee PP, Nair MP, Kandaswam C, Lee MT. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res. 2002;22:1615-1627.
50. Lee HJ, Wang CJ, Kuo HC, Chou FP, Jean LF, Tseng TH. Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol Appl Pharmacol. 2005;203:124-131.
51. Pandurangan AK, Ganapasam S. Luteolin induces apoptosis in azoxymethane-induced colon carci-nogenesis through involvement of Bcl-2, Bax, and Caspase-3. J Chem Pharm Res. 2013;5:143-148.
52. Pandurangan AK, Dharmalingam P, Anandasa-dagopan SK, Ganapasam S. Inhibitory effect of luteolin on the status of membrane bound ATPases against azoxymethane-induced colorectal cancer. J Chem Pharm Res. 2013;5:123-127.